Clinical trial · Observational
Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction
The Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction: A Prospective Analysis of 138 Flaps
NCT03106233CI-TRIAL-00026883completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The lateral thigh perforator (LTP) flap was previously introduced as an alternative flap for autologous breast reconstruction when the abdomen is not suitable as a donor site. In this prospective study all LTP flap breast reconstructions that have been performed since September 2012 are analyzed. In addition, the surgical refinements that were introduced over the years are reported.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| LTP flap | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- LTP flap breast reconstruction
- description
- All consecutive patients who underwent LTP flap breast reconstructions (unilateral, bilateral or stacked unilateral) between September 2012 and November 2016 at three centers in Maastricht, the Netherlands, and New York and New Orleans, the United States, were included. Autologous breast reconstruction was performed by using the upper lateral thigh region as a donor site.
- interventionNames
- Procedure: LTP flap
Primary outcomes (1)
- measure
- Recipient- and donor-site complications
- timeFrame
- Through study completion up to an average of 12 months post-operatively
- description
- Recipient site: Total flap loss, partial flap loss, venous congestion, infection, hematoma, seroma, fat necrosis and wound complications. Donor site: Infection, hematoma, seroma, fat necrosis, wound complications.
Secondary outcomes (1)
- measure
- Flap re-explorations
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Lateral thigh region suitable as a donor site * Abdomen not suitable as donor site * Informed consent Exclusion Criteria: * Pre-operative imaging showing no suitable perforators
References
Publications (0)
Data not yet available
No reference posted for this study.